In contrast, DT treatment had no significant effects on IDO activity, IDO1 transcription or splenomegaly in MuLV-infected WT (B6) mice (Fig 4D–4F), indicating that the effects of DT treatment were due to ablation of cells expressing DTR. This evidence concerns the gene IDO1 and Splenomegaly.